Skip to main content
OpenTrials

Clinical trial condition

Purpura

Explore clinical trials studying Purpura. Study availability and eligibility vary by location and protocol.

377 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Purpura trial results

Completed

Efficacy and Safety of IVIG-L in ITP Patients

NCT00151840

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +15 more
Locations
  • Hematology Clinic, Medical University of Bialystok Bialystok, Poland
  • Haematology Clinic, Medical University of Gdansk Gdansk, Poland
  • Clinic of Haematology, Medical University of Lodz Lodz, Poland
  • Clinical of Internal Diseases and haematology with Bone marrow Transplantation Unit, Central Academic Hospital, Medical Military Academy Warsaw, Poland
View Trial Details
Active, Not Recruiting

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias

NCT05757570

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +22 more
Locations
  • Investigational Site (230) Los Angeles, California, United States
  • Investigational Site (401) Washington D.C., District of Columbia, United States
  • Investigational Site (419) Cooper City, Florida, United States
  • Investigational Site (425) Miami, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids

NCT05653219

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
  • NorthShore University Health System Evanston, Illinois, United States
  • Boston Medical Center Boston, Massachusetts, United States
View all 77 locations
View Trial Details
Active, Not Recruiting

Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)

NCT05653349

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Yuma Regional Medical Center Yuma, Arizona, United States
  • Community Cancer Institute Clovis, California, United States
  • Compassionate Care Res Group Inc Fountain Valley, California, United States
  • University of Colorado Anschutz Aurora, Colorado, United States
View all 111 locations
View Trial Details
Active, Not Recruiting

A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

NCT05885555

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconess Med Center Boston, Massachusetts, United States
  • Novartis Investigative Site CABA, Argentina
  • Novartis Investigative Site Garran, Australian Capital Territory, Australia
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

NCT04683003

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +14 more
Locations
  • Childrens Healthcare of Atlanta Atlanta, Georgia, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Mid Ohio Heart Clinic Inc Dublin, Ohio, United States
View all 27 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

NCT04562766

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • University of Southern California_Investigational Site Number 84024 Los Angeles, California, United States
  • UCSF Benioff Children's Hospital San Francisco_Investigational Site Number 84020 San Francisco, California, United States
  • Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center_Investigational Site Number 84037 Torrance, California, United States
  • The Oncology Institute of Hope and Innovation_Investigational Site Number 84031 Whittier, California, United States
View all 155 locations
View Trial Details

Related conditions